Feasibility and Functionality of fPAM Imaging in Melanoma

Stopped early

Conditions studied: Melanoma

In brief

Melanoma is a cutaneous malignancy that has the potential for local (skin) and regional (lymph node) recurrence. These recurrences may be difficult to detect in their earliest stages. We are attempting to use novel form of skin imaging that uses ultrasound combined with laser to identify these recurrences early, when they may be most amenable to treatment. This imaging will detect melanoma pigment below the surface of the skin and in the draining lymph nodes, as well as new blood vessel formation that occurs with these loco-regional metastases.

Key facts

Study ID

NCT00776945

Run by

Washington University School of Medicine

People needed

2

Starts

2009-01-01

Expected to finish

2014-12-01

Last updated by the study team

2015-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (> 18 yrs of age) with recently diagnosed or a history of, Stage I - III melanoma who are able to give informed consent.

You may not qualify if…

• Patients with melanomas < 1mm.
• Pregnant females.
• Children and young adults < 18 yrs of age and patients who are unable to give informed consent.

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States
• Washington University — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.